Reports for MYLAN PHARMACEUTICALS ULC
Company Name
MYLAN PHARMACEUTICALS ULC
Totals |
||
Shortage reports |
650 |
|
| Actual shortage: | 13 (2%) | |
| Anticipated shortage: | 6 (1%) | |
| Avoided shortage: | 85 (13%) | |
| Resolved: | 546 (84%) | |
Discontinuation Reports |
234 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 234 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
82 (9%) |
|
Overdue reports |
0 (0%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MYLAN-BUPROPION XL | 300MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-04-17 | 2017-05-02 | 7131 |
| MYLAN-BUPROPION XL | 150MG | TABLET (EXTENDED-RELEASE) | Resolved | 2019-07-16 | 2019-07-24 | 89459 |
| MYLAN-BUPROPION XL | 150MG | TABLET (EXTENDED-RELEASE) | Resolved | 2019-08-07 | 2019-08-20 | 91041 |
| MYLAN-BUPROPION XL | 300MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-01-28 | 2020-03-26 | 104631 |
| MYLAN-BUPROPION XL | 150MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-01-28 | 2020-06-03 | 104638 |
| MYLAN-BUPROPION XL | 300MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-04-02 | 2020-07-01 | 110465 |
| MYLAN-BUPROPION XL | 150MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-10-06 | 2022-08-25 | 125767 |
| MYLAN-BUPROPION XL | 300MG | TABLET (EXTENDED-RELEASE) | Resolved | 2021-02-09 | 2022-08-25 | 133595 |
| MYLAN-BUPRENORPHINE/NALOXONE | 8MG 2MG | TABLET | Resolved | 2017-03-16 | 2019-09-18 | 3089 |
| MYLAN-BUPRENORPHINE/NALOXONE | 2MG 0.5MG | TABLET | Resolved | 2017-03-22 | 2017-04-12 | 3922 |
| MYLAN-BUPRENORPHINE/NALOXONE | 2MG 0.5MG | TABLET | Resolved | 2017-04-20 | 2019-09-18 | 7392 |
| MYLAN-BUDESONIDE AQ | 100MCG | SPRAY, METERED DOSE | Resolved | 2017-09-22 | 2020-01-21 | 23166 |
| MYLAN-BUDESONIDE AQ | 64MCG | SPRAY, METERED DOSE | Resolved | 2017-09-22 | 2020-03-04 | 23169 |
| MYLAN-BUDESONIDE AQ | 100MCG | SPRAY, METERED DOSE | Resolved | 2020-02-04 | 2020-03-04 | 105234 |
| MYLAN-BUDESONIDE AQ | 100MCG | SPRAY, METERED DOSE | Actual shortage | 2023-02-23 | 2023-12-12 | 185423 |
| MYLAN-BUDESONIDE AQ | 64MCG | SPRAY, METERED DOSE | Actual shortage | 2023-03-07 | 2023-12-12 | 186402 |
| MYLAN-BOSENTAN | 125.0MG | TABLET | Resolved | 2017-09-13 | 2017-09-23 | 22010 |
| MYLAN-BOSENTAN | 62.5MG | TABLET | Resolved | 2017-09-22 | 2018-07-03 | 23157 |
| MYLAN-BISOPROLOL | 10MG | TABLET | Avoided shortage | 2017-04-04 | 2017-07-17 | 5313 |
| MYLAN-BISOPROLOL | 5MG | TABLET | Resolved | 2017-04-13 | 2017-07-17 | 6985 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MYLAN-ACEBUTOLOL (TYPE S) | 100MG | TABLET | Discontinued | 2017-08-24 | 2018-02-15 | 20275 |
| MYLAN-ACEBUTOLOL | 400MG | TABLET | Discontinued | 2017-08-24 | 2018-07-04 | 20309 |
| MYLAN-ACEBUTOLOL | 200MG | TABLET | Discontinued | 2017-11-23 | 2018-07-04 | 30374 |
| MYLAN-ACEBUTOLOL | 100MG | TABLET | Discontinued | 2018-06-12 | 2018-07-04 | 52262 |
| MYL-SILDENAFIL | 100MG | TABLET | Discontinued | 2017-07-17 | 2017-07-17 | 16057 |
| MYL-SILDENAFIL | 25MG | TABLET | Discontinued | 2017-07-18 | 2017-10-03 | 16172 |
| MYL-SILDENAFIL | 50MG | TABLET | Discontinued | 2017-07-18 | 2018-05-02 | 16175 |
| MYL-PROPAFENONE | 150MG | TABLET | Discontinued | 2018-03-02 | 2018-03-02 | 41530 |
| MYL-PROPAFENONE | 300MG | TABLET | Discontinued | 2018-03-02 | 2018-03-02 | 41533 |
| GEMCITABINE FOR INJECTION, USP | 1G | POWDER FOR SOLUTION | Discontinued | 2017-04-13 | 2017-04-13 | 6698 |
| GEMCITABINE FOR INJECTION, USP | 2G | POWDER FOR SOLUTION | Discontinued | 2017-04-13 | 2017-04-13 | 6701 |
| ESME 28 | 20MCG 100MCG | TABLET | Discontinued | 2018-07-03 | 2018-07-04 | 53722 |
| ESME 21 | 20MCG 100MCG | TABLET | Discontinued | 2018-07-03 | 2018-07-04 | 53714 |
| AZITHROMYCIN FOR INJECTION, USP | 500MG | POWDER FOR SOLUTION | Discontinued | 2017-07-17 | 2018-02-15 | 15804 |